|Year : 2020 | Volume
| Issue : 2 | Page : 89-96
Comparing cognitive dysfunction in euthymic patients with first episode and recurrent episodes of major depression
Hanan M.E Azzam1, Ahmed A El Missiry1, Nesreen M Mohsen1, Karim A Aziz2, Heba F Hendawy1, Abdel Gawad Khalifa1, Amina A.M Negm1
1 Institute of Psychiatry, Ain Shams University, Cairo, Egypt
2 Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates
|Date of Submission||19-Dec-2019|
|Date of Decision||30-Dec-2019|
|Date of Acceptance||15-Jan-2020|
|Date of Web Publication||21-May-2020|
Karim A Aziz
Institute of Psychiatry, Faculty of Medicine, Ain Shams University, Abbasiya, PO Box 11566, Cairo
United Arab Emirates
Source of Support: None, Conflict of Interest: None
Background Euthymic patients with major depressive disorder demonstrate cognitive deficits in executive function, attention, and memory, but to date, limited amount of work has compared patients with first-episode depression (FED) with patients with recurrent episodes of depression (RED), and no studies have been conducted in the Egyptian population.
Aim The aim was to compare cognitive functions between euthymic patients after FED and patients with RED.
Participants and methods A total of 60 euthymic participants (30 with FED and 30 with RED) were administered a battery of cognitive tasks, including the Wechsler Adult Intelligence Scale, Wechsler Memory Scale, and Wisconsin Card Sorting Test.
Results Patients with RED performed significantly poorly than patients with FED on tasks measuring abstract thinking, verbal memory, working memory, verbal immediate recall, and executive functions (which included tasks for conceptualization, cognitive flexibility, shifting, planning, and sustained attention).
Conclusion There are significant differences in performance on cognitive functions between euthymic patients with FED and RED across memory tasks and executive functions but with relative sparing of tasks of general intelligence. Poorer cognitive functions may possibly be associated with recurrent episodes.
Keywords: euthymic, executive functioning, first episode depression, intelligence, major depressive disorder, memory, recurrent episodes of depression
|How to cite this article:|
Azzam HM, El Missiry AA, Mohsen NM, Aziz KA, Hendawy HF, Khalifa AG, Negm AA. Comparing cognitive dysfunction in euthymic patients with first episode and recurrent episodes of major depression. Egypt J Psychiatr 2020;41:89-96
|How to cite this URL:|
Azzam HM, El Missiry AA, Mohsen NM, Aziz KA, Hendawy HF, Khalifa AG, Negm AA. Comparing cognitive dysfunction in euthymic patients with first episode and recurrent episodes of major depression. Egypt J Psychiatr [serial online] 2020 [cited 2020 Sep 27];41:89-96. Available from: http://new.ejpsy.eg.net/text.asp?2020/41/2/89/284653
| Introduction|| |
Major depressive disorder (MDD) is a common disorder that affects more than 300 million people worldwide and is ranked by the WHO as the single largest cause of global disability (WHO, 2017). It has a high rate of chronicity and recurrence, leading to decreased productivity and absenteeism, resulting in significant economic burden (Gilmour and Patten, 2007).
Only a subset of individuals with MDD (30–40%) reach symptomatic remission after adequate treatment, and many patients do not reach premorbid levels of functioning (Bortolato et al., 2016). Cognitive dysfunction may be the primary mediator of functional impairment in MDD and refers to deficits in attention, verbal and non-verbal learning, short-term and working memory, visual and auditory processing, problem solving, processing speed, and motor functioning (McIntyre et al., 2013). Cognitive deficits were found to be present in both first and recurrent episodes of MDD (Lee et al., 2012), with cognitive symptoms present during 85–94% of the length of depressive episodes and 39–44% of the length of periods of remission (Conradi et al., 2011). MDD was found to have a clinically significant effect on psychomotor speed, declarative memory, working memory, executive functions, and attention (Papakostas, 2014), and cognitive deficits have been shown to persist even beyond the acute stages of illness in MDD (Bora et al., 2013). Meta-analyses in first-episode depression (FED) have shown significant cognitive deficits for psychomotor speed, attention, visual learning, memory, and all aspects of executive functioning (Lee et al., 2012), with remission associated with normalization of function in processing speed, learning and memory, autobiographical memory, shifting, and intelligence quotation (IQ) but persistent impairment in inhibition and verbal fluency (Ahern and Semkovska, 2017). With recurrent episodes of depression (RED), there is a decrease in cognitive function, and interepisode cognitive function is related to the number of previous episodes (Conradi et al., 2011). Dotson et al. (2010) demonstrated that depression in general, and particularly recurrent depression, was a risk factor for developing later dementia. It has therefore been suggested that cognitive impairments are one of the main reasons for the lag between syndromal and functional recovery in patients with MDD (McIntyre et al., 2013), which may lead to the loss of productivity and an increased economic burden of the illness (Gilmour and Patten, 2007). Hence, there has been increasing recognition that symptomatic remission is an insufficient goal of treatment for MDD and that return to premorbid psychosocial functioning should be the target (Zimmerman et al., 2004).
Egypt is the most populated Arab country with a population of almost 95 million people (∼1% of the world’s population and ∼20% of all Arabs) (Population of The World, 2019). MDD has been shown to have a high prevalence in the Middle East (Ferrari et al., 2013), and in Egypt, it has a prevalence of 2.7% (Ghanem et al., 2009). Few studies in Egypt have looked at cognitive dysfunctions in MDD. Abdel Aal et al. (2018) demonstrated deficits in working memory, short-term memory, and information processing, and Sarhan et al. (2015) demonstrated deficits on all domains of the Wechsler Adult Intelligence Scale (WAIS) and Wechsler Memory Scale. Both studies were conducted in Egyptian patients with symptomatic MDD. To the best of our knowledge, no previous studies have specifically compared cognitive dysfunction in euthymic patients with first episode compared with RED. Therefore, we aimed to investigate the patterns of cognitive dysfunction in euthymic patients with MDD and investigate differences between patients experiencing FED compared with those with RED. We hypothesized that there is greater cognitive impairment in euthymic patients with RED compared with patients with a first episode of depression (FED).
Participants and methods
Operational definition of euthymia
We used a cross-sectional observational comparative study where we defined euthymia as patients who fulfilled the Diagnostic and Statistical Manual of mental disorders 4th edition (DSM IV) criteria for major depression and obtained a score less than 7 on Hamilton Rating Scale for Depression and reported being euthymic for at least 6 months.
Site of the study
The study was carried out at the outpatient department of the Institute of Psychiatry, Ain Shams University Hospitals, Cairo, Egypt. We recruited potential participants who attended for follow-up and medication renewal. They were then screened to determine their eligibility for participation in the study.
We recruited 60 Egyptian male and female participants (30 with FED and 30 with RED), aged 18–50 years, who met the DSM-IV criteria for major depression and the operational definition for euthymia. We excluded participants who had a co-morbid axis I disorder, significant uncontrolled medical or neurological diseases, learning disabilities, those who received electroconvulsive therapy in the previous 6 months, and participants who could not read and write. We also excluded patients with psychotic features in previous episodes, as they may confer increased risk to develop cognitive dysfunction (Bortolato et al., 2015). The sample size of 30 participants for each study group was calculated using the Epi-Info program Version 7.1.5 (2015).
The study was conducted according to the Helsinki Declaration of 1975, and it was approved by the Research and Ethics Committee of Ain Shams University. Participants signed an informed consent form detailing the research process, the confidentiality, and voluntariness of the participation.
The Structured Clinical Interview for DSM-IV (First et al., 1996)
This was used to confirm psychiatric diagnosis of major depression according to DSM-IV criteria. We used the translated Arabic version (El Missiry et al., 2003).
The Hamilton Rating Scale for Depression (Hamilton, 1960)
This was used to measure the severity of depressive symptoms, with a score of 0–7, indicating euthymia.
The Wechsler Adult Intelligence Scale (Wechsler, 1981)
This was used as an individually administered test of general intelligence reflecting both verbal and performance abilities and as a broad assessment of cognitive functions. It consists of 11 separate subtests, which are broken down into the verbal scale (six subtests) and the performance scale (five subtests). Each patient received a full-scale IQ score, a verbal IQ score, a performance IQ score, and scaled scores on each of the subtests. We used the Arabic standardized version (Melika, 1996).
The Wechsler Memory Scale (Wechsler, 1987)
This was used to assess memory functions and includes information and orientation questions, eight short-term memory tasks, and four delayed recall trials. Summary scores include general memory, verbal memory, visual memory, attention/concentration, and delayed recall. These indices reflect disturbances in memory function and also show certain disease-associated patterns of memory impairment.
Wisconsin Card Sorting Test, computerized version (Heaton and Saff, 2003)
This was used to assess abstraction ability and the ability to shift cognitive strategies in response to changing environmental contingencies and as a measure of frontal lobe executive function; it also provides information on several aspects of problem-solving behavior beyond such basic indices.
Recruited patients who fulfilled the criteria of the study and who gave informed consent were enrolled. They were further assessed by two senior psychiatrists to confirm the diagnosis before applying the neuropsychological battery, which was performed by an experienced clinical psychologist.
Data were recorded and analyzed using the Statistical Package for the Social Sciences (SPSS) for Windows, Version 18.0 (2011) (IBM, Armonk, New York, USA). The results were tabulated, grouped, and statistically analyzed using the Student’s t-test to assess the statistical significance between the two study group means (quantitative data). The χ2-test was used to test the significance of the differences between the frequencies of different observations (qualitative data). A P value of less than 0.05 was used to indicate statistical significance.
| Results|| |
Socio-demographic and clinical characteristics
A total of 60 eligible participants with major depressive disorder (MDD) participated in the study, of whom 48 (80%) were males and 12 (20%) were females. The first patient group included 30 participants (24 males and six females) in the euthymic phase of MDD after FED. The second patient group included 30 participants (24 males and six females) in the euthymic phase of MDD after RED.
The FED group was significantly younger than RED group (P=0.001). Years of education were comparable across the two groups (P=0.4), and none of the patients in FED group was married compared with 53.33% of the patients in RED group (P<0.001). There were no significant differences regarding the mean age of the first episode in both groups, whereas RED group had significantly longer duration of the last episode (5.733 months) compared with only 4.733 months in the FED group (P=0.003). Overall, 80% of the FED group did not report a history of childhood abuse compared with 46.67% of the RED group (P=0.007), whereas 93.3% of the FED group reported a family history of depression compared with the 73.33% of the RED group (P=0.002). There were no significant differences in the medication received by the two studied groups.
Assessment of general intellectual abilities
Except on the similarities subtest (which measures abstract thinking), there was no statistically significant difference between patients with FED and those with RED on all other domains of the WAIS, which measured visual perception, visiomotor coordination, psychomotor speed, storage of mathematical process, and total verbal and performance abilities ([Table 1] and [Table 2]).
|Table 2 Wechsler Adult Intelligence Scale and Wechsler Memory Scale: comparison between patients with first episode and recurrent episode|
Click here to view
Assessment of memory functions
On the Wechsler Memory Scale, patients with RED showed significantly poorer scores on subtests measuring verbal memory (P<0.001), verbal immediate recall (P=0.006), working memory (P<0.001), and visual immediate recall (P=0.001) compared with patients with FED. Subtests measuring verbal and visual delayed recall showed no significant difference between the two groups ([Table 2]).
Assessment of executive functions
On the Wisconsin Card Sorting Test, patients with FED obtained significantly higher scores than patients with RED on the total correct scores, conceptual level responses, categories completed, and % conceptual level response, reflecting that they were better in conceptualization, planning, and problem solving. On the contrary, patients with RED obtained higher scores on perseveration responses, perseverative errors, and % perseverative responses, reflecting that they were worse on tasks measuring shifting and cognitive flexibility ([Table 3]).
|Table 3 Wisconsin Card Sorting Test comparison between patients with first episode and recurrent episode|
Click here to view
| Discussion|| |
Cognitive dysfunction is among the most frequently reported residual symptoms in depression, which is an important mediator of functioning, including workplace performance, psychosocial functioning, and quality of life (Ekman et al., 2013; Bortolato et al., 2016; Woo et al., 2016). Cognitive dysfunction in depression remains largely under-recognized, unmonitored, and under-treated (McAllister-Williams et al., 2017; Zuckerman et al., 2018). Thus, recognition and management of cognitive dysfunction remains an unmet need in the treatment of MDD and should be addressed in the therapeutic approach of depression (Albert et al., 2016).
Our study aimed to assess cognitive functions among euthymic patients with MDD with FED compared with patients with RED.
Overall, our findings showed that euthymic patients with RED showed significant impairment of cognitive functions compared with patients with first episode across tests of memory and executive functions, with relative sparing on tests of general intelligence.
Mixed results have been demonstrated regarding the presence of cognitive dysfunction in euthymic patients with major depression (Wang et al., 2006; Delaloye et al., 2010). Hasselbalch et al. (2013) reported persistent deficits in cognitive functions in a large systematic review of 11 studies involving 500 patients with MDD in remission. Hammar et al. (2010) suggested that persistent cognitive dysfunction in euthymia is not an epiphenomena of mood symptoms but is rather a core persisting phenomenon.
Similar to our findings, Talarowska et al. (2015) reported significant differences in performance on cognitive tasks among patients with RED compared with patients with FED. Vanderhasselt and De Raedt (2009) suggested that deficits of cognitive function with each depressive episodes after symptom remission may be a scar of cognitive control. Other interpretations of the coexistence of cognitive deficits and depressive illness were suggested by Sarapas et al. (2012) who stated that it may be a trait-like relationship and as a state effect. de Diego-Adeliño et al. (2013) added that the worsening of cognitive performance in patients with RED may be related to the presence of structural and functional changes in the hippocampus and frontal lobes, which appear after frequent episodes.
Regarding general intellectual abilities, our study did not find significant differences in the WAIS subtests between the two studied euthymic groups except in similarities subtest, which reflected worse abstract ability in the RED group. Although general intelligence seems to be impaired in acute episodes of depression, it is not considered a primary disturbance in euthymic phase (Marazziti et al., 2010), which was consistent with our results. In a meta-analysis involving 994 patients with FED, Ahern and Semkovska (2017) denoted that small to large impairments were observed in IQ functions in patients with FED compared with healthy controls, which normalized with remission of symptoms.
Patients with FED performed significantly better compared with patients with RED on tests of memory functions, namely, verbal memory, working memory, immediate recall, and visual immediate recall. Similar to our study, Talarowska et al. (2015) demonstrated that FED group performed better than RED group on auditory-verbal memory, auditory-verbal immediate and delayed memory, and the ability to learn, and that these differences were visible from as early as the second episode of a MDD. A possible explanation for these findings may be related to the effect of major depression on memory. Maeshima et al. (2012) investigated patients with single and recurrent major depressive episodes and found that at the time of initial remission, scores of both logical memory and visual reproduction were significantly lower in both patient groups compared with healthy controls. At follow-up after 3 years, memory dysfunction of the single-episode group disappeared, whereas scores in the recurrent group remained significantly lower than those of the single-episode group and controls (Maeshima et al., 2012). This might explain why patients with RED performed worse than patients with FED in our study.
Smith et al. (2013) found no association between the number of episodes in euthymic patients with MDD and deficits in cognitive performance including working and verbal memory. However, they also noted that the lack of association may be masked by the participants’ level of education (Smith et al., 2013). Similarly, the meta-analysis by Ahern and Semkovska (2017) showed that compared with healthy controls, remission in patients with FED was associated with a normalization of function in learning and memory (especially autobiographical memory) but that lower FED age was associated with more impairment in word-list delayed memory (Ahern and Semkovska, 2017).
In the current study, patients with RED obtained significantly lower scores on tasks measuring verbal immediate recall, visual immediate recall, abstract thinking, and working memory. Previous studies demonstrated that patients with FED performed better than patients with RED on auditory-verbal memory, auditory-verbal immediate, and delayed memory and the ability to learn, and that these differences were visible from as early as the second episode of MDD (Talarowska et al., 2015). Verbal memory was an area of consistent impairment in patients with remitted MDD and one of the cognitive deficits that were the principal mediators of occupational impairment in these patients (Woo et al., 2016).
Executive functions involve handling novel situations, planning, decision-making, error correction, abstract ability, and shifting of response to changing environmental situations (Marazziti et al., 2010). In the current study, we reported more impairment of executive functions in patients with RED versus patients with FEB in terms of conceptualization, shifting, planning, cognitive flexibility, and problem solving.
Using other tools of assessment such as trail-making test and stroop test, Talarowska et al. (2015) found that patients with FED performed better compared with patients with RED on tests of executive functions, and those differences were already visible from the second episode of depression. The findings that patients with euthymic/remitted MDD exhibited deficits in executive functions compared with healthy controls has been demonstrated in numerous studies (Biringer et al., 2005; Paelecke-Habermann et al., 2005; Smith et al., 2013). The meta-analysis by Bora et al. (2013) looked at 27 studies that included 895 participants and concluded that healthy controls significantly outperformed euthymic patients with MDD on all cognitive domains, including the Wisconsin Card Sorting Test (except for perseveration), with late-onset cases showing more pronounced deficits on some executive functions. Ahern and Semkovska (2017) found a significant difference in patients with FED compared with healthy controls on executive functions, with normalization of set-shifting with remission of symptoms. Previous studies reported marked impairment in inhibition (Ahern and Semkovska, 2017) and difficulties in cognitive flexibility, with cognitive rigidity preventing patients from coping with life events (Marazziti et al., 2010).
Conclusion and clinical implications
The current study demonstrated that euthymic patients with recurrent major depression have significantly more impaired cognitive functions than those with first episode across memory and executive functions, with relative sparing of general intelligence. The cognitive control in depression may be reduced after recurrence of depressive episode, and it seems that cognitive symptoms may have a progressive nature and might leave a scar after each episode. In clinical practice, we suggest that it should be mandatory to screen for and treat cognitive dysfunctions in addition to mood symptoms to achieve functional as well as symptomatic recovery in depression.
Strengths and limitations
The novelty of this study is that, to the best of our knowledge, it is the first study in Egypt to investigate cognitive dysfunctions among euthymic patients with major depression after first and recurrent episodes. However, this study was limited by the number of participants and by the cross-sectional nature of the study where we could not infer any direct causal effect between MDD and cognitive functions. It is unclear from our study if cognitive symptoms preceded depression (trait marker) or developed and progressed after recurrent episodes (state marker). A longitudinal study following up participants over the course of their illness should help address these limitations. Another limitation was is that we did not compare patients with healthy controls. Further studies that address differences in cognitive functions between healthy participants and euthymic patients with depression and that explore the relation of cognitive functions to clinical course, functioning, and outcome can help in identification and prediction of relapse, which ultimately can help inform us about unmet needs in the management of patients with depression.
This study was made possible by the generous support and guidance of Professor Afaf Hamed Khalil, Professor of Psychiatry, Ain Shams University.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Abdel Aal M, Molokhia T, El Kholy O, Sheshtawy H (2018). Cognitive dysfunction profile in a sample of Egyptian patients experiencing major depressive disorder. Egypt J Psychiatr 39:66.
Ahern E, Semkovska M (2017). Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis. Neuropsychology 31:52–72.
Albert U, Brugnoli R, Caraci F, Dellosso B, Di Sciascio G, Tortorella A, Pegoraro V (2016). Italian psychiatrists perception on cognitive symptoms in major depressive disorder. Int J Psychiatr Clin Pract 20:2–9.
Biringer E, Lundervold A, Stordal K, Mykletun A, Egeland J, Bottlender R, Lund A (2005). Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiatr Clin Neurosci 255:373–380.
Bora E, Harrison BJ, Yücel M, Pantelis C (2013). Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 43:2017–2026.
Bortolato B, Carvalho A, McIntyre R (2015). Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord 13:1804–1818.
Bortolato B, Miskowiak KW, Köhler CA, Maes M, Fernandes BS, Berk M, Carvalho AF (2016). Cognitive remission: A novel objective for the treatment of major depression?. BMC Med 14:XX.
Conradi HJ, Ormel J, De Jonge P (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med 41:1165–1174.
de Diego-Adeliño J, Portella MJ, Gómez-Ansón B, López-Moruelo O, Serra-Blasco M, Vives Y, Pérez V (2013). Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. J Psychiatr Neurosci 38:107–116.
Delaloye C, Moy G, De Bilbao F, Baudois S, Weber K, Hofer F, Gold G (2010). Neuroanatomical and neuropsychological features of elderly euthymic depressed patients with early- and late-onset. JNeurol Sci 299:19–23.
Dotson VM, Beydoun MA, Zonderman AB (2010). Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75:27–34.
Ekman M, Granström O, Omérov S, Jacob J, Landén M (2013). The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care. J Affect Disord 150:790–797.
El Missiry A, Sorour A, Sadek A, Fahy T, AbdelMawgoud M, Asaad T (2003). Homicide and psychiatric illness: an Egyptian study [MD Thesis]. Cairo: Faculty of Medicine, Ain Shams University
Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA (2013). Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 43:471–481.
First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press Inc.
Ghanem M, Gadallah M, Meky FA, Mourad S, El-Kholy G (2009). National survey of prevalence of mental disorders in Egypt: preliminary survey. Eastern Mediterranean Health J 15:65–75.
Gilmour H, Patten SB (2007). Depression and work impairment. Health Rep 18:9–22.
Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
Hammar Ås, Sørensen L, Årdal G, Oedegaard KJ, Kroken R, Roness A, Lund A (2010). Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm. Scandinavian J Psychol 51:304–308.
Hasselbalch BJ, Knorr U, Hasselbalch SG, Gade A, Kessing LV (2013). The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur Psychiatr 28: 349–355.
Heaton RK, Saff PAR. (2003). Wisconsin Card Sorting Test: Computer version 4 (WCST:CV4). Lutz, FL: Psychological Assessment Resources
IBM Corp. (2011). IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.
Lee RSC, Hermens DF, Porter MA, Redoblado-Hodge MA (2012). A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord
Maeshima H, Baba H, Nakano Y, Satomura E, Namekawa Y, Takebayashi N, Arai H (2012). Residual memory dysfunction in recurrent major depressive disorder − a longitudinal study from Juntendo University Mood Disorder Project. J Affect Disord 143:84–88.
Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L (2010). Cognitive impairment in major depression. Eur J Pharmacol 626:83–86.
McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Young AH (2017). Analysing UK clinicians’ understanding of cognitive symptoms in major depression: a survey of primary care physicians and psychiatrists. J Affect Disord 207: 346–352.
McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Baskaran A (2013). Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depression Anxiety 30:515–527.
Melika LK (1996). Wechsler Intelligence Scale for Adults and Adolescents. Cairo: El-Nahda Egyptian Library.
Paelecke-Habermann Y, Pohl J, Leplow B (2005). Attention and executive functions in remitted major depression patients. J Affect Disord 89:125–135.
Papakostas GI (2014). Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatr 75:8–14.
Sarapas C, Shankman SA, Harrow M, Goldberg JF (2012). Parsing trait and state effects of depression severity on neurocognition: evidence from a 26-year longitudinal study. J Abnormal Psychol 121:830–837.
Sarhan Z, Fathy H, Madbouly N (2015). Cognitive impairment in depressed students of Cairo University Hospital. Egypt J Psychiatry 36:54.
Smith DJ, Nicholl BI, Cullen B, Martin D, Ul-Haq Z, Evans J, Pell JP (2013). Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172, 751 participants. PLoS One 8:XX.
Talarowska M, Zajàczkowska M, Gałecki P (2015). Cognitive functions in first-episode depression and recurrent depressive disorder. Psychiatria Danubina 27:38–43.
Vanderhasselt MA, De Raedt R (2009). Impairments in cognitive control persist during remission from depression and are related to the number of past episodes: An event related potentials study. Biol Psychol 81:169–176.
Wang CE, Halvorsen M, Sundet K, Steffensen AL, Holte A, Waterloo K (2006). Verbal memory performance of mildly to moderately depressed outpatient younger adults. J Affective Disord 92:283–286.
Wechsler D (1981). WAIS-R: Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corporation.
Wechsler D (1987). WMS-R: Wechsler Memory Scale − Revised: Manual. San Antonio: Psychological Corp: Harcourt Brace Jovanovich
WHO. (2017). Depression and other common mental disorders: global health estimates. Geneva: World Health Organization.
Woo YS, Rosenblat JD, Kakar R, Bahk WM, McIntyre RS (2016). Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clinical Psychopharmacology and Neuroscience. Korean Coll Neuropsychopharmacol 14:1–16. https://doi.org/10.9758/cpn.2016.14.1.1
Zimmerman M, Posternak MA, Chelminski I (2004). Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 38:577–582.
Zuckerman H, Pan Z, Park C, Brietzke E, Musial N, Shariq AS, McIntyre RS (2018). Recognition and treatment of cognitive dysfunction in major depressive disorder. Front Psychiatr, 9.
[Table 1], [Table 2], [Table 3]